Market Tracker

02/24 5:16pm ET

Sangamo Therapeutics Inc (NASDAQ:SGMO)

4.00
Delayed Data
As of Feb 24
 +0.15 / +3.90%
Today’s Change
2.65
Today|||52-Week Range
7.60
+31.15%
Year-to-Date
No recent news for Sangamo Therapeutics Inc.

Today’s Trading

Previous close3.85
Today’s open3.75
Day’s range3.75 - 4.05
Volume644,689
Average volume (3 months)845,859
Market cap$282.5M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-48.72%
Earnings growth (this year)-95.44%
Earnings growth (next 5 years)+24.50%
Revenue growth (last year)-13.80%
P/E ratioNM
Price/Sales16.11
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
ADAPAdaptimmune Therapeu...0.000.00%
RIGLRigel Pharmaceutical...-0.02-0.86%
EDGEEdge Therapeutics In...+0.09+0.90%
KMDAKamada Ltd+0.10+1.34%
Data as of 4:00pm ET, 02/24/2017

Financials

Last reporting dateFebruary 20, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$39.5M
Annual profit (last year)-$40.7M
Net profit margin-102.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Alexander Macrae
Chief Financial Officer &
Executive Vice President
Henry Ward Wolff
Corporate headquarters
Richmond, California

Forecasts